Skip to content
The Nexus
DossierENTITY

Anvisa

Coverage of Anvisa in the Nexus archive.

Earliest in view: Jul 9 · 16:20 UTCMost recent: Jul 9 · 16:20 UTC
Co-mentioned in this coverage
Brazilplace1Paraguayplace1Unicamp toxicology centreorganization1tirzepatidetopic1weight-loss penstopic1
Recent coverage
  • HEALTHJul 9 · 16:20 UTCTHE RIO TIMES
    Brazil Says Paraguay’s Weight-Loss Pens Are Not the Same Drug

    Brazil's medicines regulator, Anvisa, stated that Paraguay's weight-loss pens are not equivalent to the drug tirzepatide. Tests by Unicamp's toxicology centre confirmed the presence and concentration of tirzepatide in smuggled vials but did not assess impurities, contaminants, or sterility.

Anvisa · Dossier · The Nexus